ULBI

Several events impacted Ultralife Corp.'s stock price over the past six months. The company reported its third-quarter results on November 18, 2025, and its fourth-quarter results on March 10, 2026, with a GAAP EPS of -$0.45 and revenue of $48.48 million. On May 8, 2026, Ultralife reported its Q1 2026 earnings, posting a net loss of $0.03 per share, missing analyst estimates, which caused the stock to drop 12.77% in pre-market trading. Ultralife insiders have exclusively purchased company stock, with 13 purchases and no sales. As of May 1, 2026, the share price was $6.86, representing an increase of 51.43% over the past year.